Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabeprazole for Prevention of Recurrent Ulcers with Low-dose Aspirin
NCT01398410Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Dec 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rabeprazole in gastric ulcer, duodenal ulcer, sponsored by Eisai Co., Ltd.. Started Dec 2011; status: completed.
02
Drugs
rabeprazole
03
Conditions
gastric ulcerduodenal ulcer
Beyond the preview
Go deeper on NCT01398410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01398410.